The gateway to guanine nucleotides: Allosteric regulation of IMP dehydrogenases

被引:17
作者
Buey, Ruben M. [1 ]
Fernandez-Justel, David [1 ]
Jimenez, Alberto [1 ]
Revuelta, Jose L. [1 ]
机构
[1] Univ Salamanca, Dept Genet & Microbiol, Metab Engn Grp, Salamanca, Spain
关键词
allosteric regulation; enzyme filamentation; IMP dehydrogenase; protein structure and function; purine nucleotide biosynthesis; INOSINE 5'-MONOPHOSPHATE DEHYDROGENASE; DOMINANT RETINITIS-PIGMENTOSA; MONOPHOSPHATE DEHYDROGENASE; 5-MONOPHOSPHATE DEHYDROGENASE; BINDING; MUTATIONS; DISEASE; GENE; CYCLOPHILIN; METABOLISM;
D O I
10.1002/pro.4399
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Inosine 5 '-monophosphate dehydrogenase (IMPDH) is an evolutionarily conserved enzyme that mediates the first committed step in de novo guanine nucleotide biosynthetic pathway. It is an essential enzyme in purine nucleotide biosynthesis that modulates the metabolic flux at the branch point between adenine and guanine nucleotides. IMPDH plays key roles in cell homeostasis, proliferation, and the immune response, and is the cellular target of several drugs that are widely used for antiviral and immunosuppressive chemotherapy. IMPDH enzyme is tightly regulated at multiple levels, from transcriptional control to allosteric modulation, enzyme filamentation, and posttranslational modifications. Herein, we review recent developments in our understanding of the mechanisms of IMPDH regulation, including all layers of allosteric control that fine-tune the enzyme activity.
引用
收藏
页数:16
相关论文
共 92 条
  • [31] The Bateman domain of IMP dehydrogenase is a binding target for dinucleoside polyphosphates
    Fernandez-Justel, David
    Pelaez, Rafael
    Luis Revuelta, Jose
    Buey, Ruben M.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (40) : 14768 - 14775
  • [32] A Nucleotide-Dependent Conformational Switch Controls the Polymerization of Human IMP Dehydrogenases to Modulate their Catalytic Activity
    Fernandez-Justel, David
    Nunez, Rafael
    Martin-Benito, Jaime
    Jimeno, David
    Gonzalez-Lopez, Adrian
    Maria Soriano, Eva
    Luis Revuelta, Jose
    Buey, Ruben M.
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2019, 431 (05) : 956 - 969
  • [33] Inosine 5′-Monophosphate Dehydrogenase (IMPDH) as a Potential Target for the Development of a New Generation of Antiprotozoan Agents
    Fotie, Jean
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2018, 18 (08) : 656 - 671
  • [34] GILBERT HJ, 1979, BIOCHEM J, V183, P481, DOI 10.1042/bj1830481
  • [35] A novel IMPDH1 mutation (Arg231Pro) in a family with a severe form of autosomal dominant retinitis pigmentosa
    Grover, S
    Fishman, GA
    Stone, EM
    [J]. OPHTHALMOLOGY, 2004, 111 (10) : 1910 - 1916
  • [36] Impact of Allosteric Modulation in Drug Discovery: Innovation in Emerging Chemical Modalities
    Han, Bingsong
    Salituro, Francesco G.
    Blanco, Maria-Jesus
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (10): : 1810 - 1819
  • [37] ANKRD9 is a metabolically-controlled regulator of IMPDH2 abundance and macro-assembly
    Hayward, Dawn
    Kouznetsova, Valentina L.
    Pierson, Hannah E.
    Hasan, Nesrin M.
    Guzman, Estefany R.
    Tsigelny, Igor F.
    Lutsenko, Svetlana
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (39) : 14454 - 14466
  • [38] IMP Dehydrogenase: Structure, Mechanism, and Inhibition
    Hedstrom, Lizbeth
    [J]. CHEMICAL REVIEWS, 2009, 109 (07) : 2903 - 2928
  • [39] Jayaram HN, 1999, CURR MED CHEM, V6, P561
  • [40] Regulation of the interaction of inosine monophosphate dehydrogenase with mycophenolic acid by GTP
    Ji, YS
    Gu, JJ
    Makhov, AM
    Griffith, JD
    Mitchell, BS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (01) : 206 - 212